| abstract |
In accordance with the present invention, fully human monoclonal antibodies or antigen binding portions thereof that specifically bind to CD137 are disclosed. On the one hand, a CDR / variable region sequence of the antibody and a nucleic acid sequence encoded by the antibody are provided, and on the other hand, a disease treatment method using the antibody or an antigen-binding portion thereof is provided. [Selection] Figure 11 |